Clinical trials
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria for current study were Omani men and women aged 18 to 75 years old, diagnosed with Type 2 diabetes, and receiving diabetes care from the NDEC with stable HbA1c less than 10% for at least 6 months.
Exclusion criteria
Exclusion criteria: Men and women who were severely impaired in vision, hearing, or speech. Additionally, Pregnant or lactating women and individuals who are diagnosed with cardiac failure or/and severe renal disease, with physical or mental disability, neurological or cognitive impairment. Individuals who have known allergy to peanuts/ or any components of the Mediterranean diet were excluded also. Control group will be invited to the clinic in different days / clinic slots to avoid any possibility of contamination between them and intervention subjects. In addition, subjects in the control group will be assured that they will receive the same information as the intervention subjects at the end of the study. In order to avoid any risks, patients with any type of known allergies related to Mediterranean diet will be excluded from the study. Subjects will be advised on potential symptoms of allergies. Clear instruction will be provided that subjects presented with allergies symptoms will need to seek medical treatment immediately.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcomes: Decrease the Risk of cardiovascular: HbA1c Blood lipid profile (TG, LDL HDL, Total cholesterol/ HDL ratio) Blood pressure (Systolic and diastolic) Anthropometric measurements (Body mass index) | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes: psychosocial factors dietary behaviors | — |
Countries
Asia(except Japan)
Contacts
Universiti Putra Malaysia Department of Nutrition and Dietetics